CTOs on the Move

Regal Medical Group

www.regalmed.com

 
Regal Medical Group is dedicated to delivering high quality of care with an emphasis of continuously improving service quality. Some of the benefits of being a Regal Provider are the tools and support we give the providers to effectively care for the
  • Number of Employees: 250-1000
  • Annual Revenue: $500M-1 Billion
  • www.regalmed.com
  • 8510 Balboa Blvd Ste 150
    Northridge, CA USA 91325
  • Phone: 818.654.3400

Executives

Name Title Contact Details

Similar Companies

Oliver Medical Packaging

Oliver Medical Packaging, LLC is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maxant Technologies

Maxant Technologies is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ivek

Ivek Corp. is a North Springfield, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Icare Industries

Icare Industries is a Saint Petersburg, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

T2 Biosystems

At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.